Mansoor Raza Mirza has sold KPTI and made no open-market buys since Sep 2017
Director at Karyopharm Therapeutics Inc.
SEC CIK 0001588389 · Filings on SEC.gov ↗
$0Bought
$1.3MSold
NoneLast buy
Every filing
13 filings since Sep 2017, newest first
KPTISell
Karyopharm Therapeutics Inc.
Director
$90K−100.0%Dec 22
KPTISell
Karyopharm Therapeutics Inc.
Director
$321K−100.0%Dec 8
KPTISell
Karyopharm Therapeutics Inc.
Director
$118K−100.0%Mar 4
KPTISell
Karyopharm Therapeutics Inc.
Director
$41K−100.0%Jan 13
KPTISell
Karyopharm Therapeutics Inc.
Director
$59K−100.0%Dec 31
KPTISell
Karyopharm Therapeutics Inc.
Director
$208K−100.0%Dec 20
KPTISell
Karyopharm Therapeutics Inc.
Director
$176K−100.0%Dec 11
KPTISell
Karyopharm Therapeutics Inc.
Director
$53K−100.0%Sep 4
KPTISell
Karyopharm Therapeutics Inc.
Director
$50K−100.0%Aug 30
KPTISell
Karyopharm Therapeutics Inc.
Director
$36K−100.0%May 11
KPTISell
Karyopharm Therapeutics Inc.
Director
$43K−100.0%Mar 14
KPTISell
Karyopharm Therapeutics Inc.
Director
$40K−100.0%Mar 6
KPTISell
Karyopharm Therapeutics Inc.
Director
$32K−100.0%Sep 18
Filings come from SEC EDGAR. Not investment advice.